VYT — Vytrus Biotech SA Income Statement
0.000.00%
Last trade - 00:00- €15.49m
- €16.46m
- €3.74m
- 69
- 20
- 38
- 34
Annual income statement for Vytrus Biotech SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.22 | 1.7 | 2.8 | 3.68 | 3.74 |
| Cost of Revenue | |||||
| Gross Profit | 1.58 | 1.5 | 2.38 | 3.03 | 3.12 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1.45 | 1.5 | 2.37 | 3.04 | 3.28 |
| Operating Profit | -0.228 | 0.208 | 0.43 | 0.645 | 0.454 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.324 | 0.092 | 0.309 | 0.453 | 0.308 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.073 | 0.217 | 0.45 | 0.605 | 0.545 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.073 | 0.217 | 0.45 | 0.605 | 0.545 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.073 | 0.217 | 0.45 | 0.605 | 0.545 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.004 | 0.027 | 0.065 | 0.088 | 0.079 |